Trials / Completed
CompletedNCT02540213
Observational Study of MIRCERA in Users of Self-Application and Multidose Systems
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This non-interventional, observational study investigates the efficiency, safety and acceptance of MIRCERA in participants, who received erythropoiesis stimulating agent (ESA) using a self-application system. For each participant, the investigator documents 9 months of treatment with Mircera with respect to efficacy, safety and acceptance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MIRCERA | Methoxy polyethylene glycol epoetin beta (0.6 mcg/kg q2w) will be administered using MIRCERA ready-to-use-syringes up to 9 months. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2015-09-03
- Last updated
- 2015-12-22
- Results posted
- 2015-12-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02540213. Inclusion in this directory is not an endorsement.